Heart valve device sales are booming in Europe

An aging population and greater use of new technology will drive Europe's heart valve device market to grow more than 10% annually through 2016, Millennium Research Group concludes. Countries particularly affected: France, Germany, Italy and the United Kingdom. Greater use of premium-priced transcatheter heart valve devices expand the pool of patients who can undergo heart valve procedures, the analysts argue, noting that continued innovation should bring more competitors into the market place. In addition, countries such as Germany have boosted their reimbursements for new technology, creating a boost in procedures. Millennium also predicts the aging population will fuel growth. Release

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.